Endometriosis and menopausal hormone therapy impact the hysterectomy-ovarian cancer association
article
OA: bronze
CC0
⤵ 7 in-corpus citations
AI-generated summary
This study examined how endometriosis and menopausal hormone therapy influence the association between hysterectomy and ovarian cancer risk.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (46)
- Educational level, prevalence of hysterectomy, and age at amenorrhoea: a cross-sectional analysis of 9536 women from six population-based cohort studies in Germany via openalex
- Endometriosis via openalex
- Epidemiology of Hysterectomy in the United States: Demographic and Reproductive Factors in a Nationally Representative Sample via openalex
- Hormonal and surgical treatments for endometriosis and risk of epithelial ovarian cancer via openalex
- Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis via openalex
- Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium via openalex
- Recurrence of endometriosis after hysterectomy. via openalex
- Risk of epithelial ovarian cancer in relation to benign ovarian conditions and ovarian surgery via openalex
- Talcum powder, chronic pelvic inflammation and NSAIDs in relation to risk of epithelial ovarian cancer via openalex
- The Association Between Hysterectomy and Ovarian Cancer Risk: A Population-Based Record-Linkage Study via openalex
- W1998758784 via openalex
- W2000051775 via openalex
- W2023097594 via openalex
- W2035715254 via openalex
- W2037812289 via openalex
- W2070928553 via openalex
- W2091462791 via openalex
- W2095122629 via openalex
- W2108526841 via openalex
- W2121431805 via openalex
- W2125681453 via openalex
- W2140155041 via openalex
- W2140963269 via openalex
- W2152298336 via openalex
- W2158308549 via openalex
- W2203514186 via openalex
- W2338934203 via openalex
- W2485415683 via openalex
- W2593754018 via openalex
- W2606888643 via openalex
- W2735861455 via openalex
- W2740474861 via openalex
- W3134885188 via openalex
- W4240296991 via openalex
- W6676209443 via openalex
- W1820292365 via openalex
- W6690080468 via openalex
- W1840787377 via openalex
- W1876840513 via openalex
- W1964507315 via openalex
- W1966460562 via openalex
- W1976198926 via openalex
- W1988990531 via openalex
- W1990063978 via openalex
- W1993578102 via openalex
- W1996568521 via openalex
Cited by (7)
- Lignes directrices de pratique clinique n° 468 : Prise en charge clinique de l'endométriose 2026
- Research progress in endometriosis-associated ovarian cancer 2024
- Endometriosis and menopause—management strategies based on clinical scenarios 2023
- Hysterectomy and risk of epithelial ovarian cancer by histologic type, endometriosis, and menopausal hormone therapy 2023
- Racial Differences in the Association of Endometriosis and Uterine Leiomyomas With the Risk of Ovarian Cancer 2023
- Hysterectomy and risk of epithelial ovarian cancer by histologic type, endometriosis, and menopausal hormone therapy 2022
- Effects of risk factors for ovarian cancer in women with and without endometriosis 2022
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:24:08.918168+00:00
License: CC0
· commercial use OK